Nav: Home

Study shows COPD is associated with significant and persistent pain

May 21, 2013

ATS 2013, PHILADELPHIA - Chronic obstructive pulmonary disease (COPD) is primarily associated with the respiratory symptoms that are its hallmark, but in fact, patients who struggle with the disease also experience significant amounts of chronic pain. A new study conducted by researchers in Pennsylvania and New Mexico estimates the degree of pain suffered by these patients to be close to that experienced by patients with osteoarthritis and rheumatoid arthritis.

The research results will be presented at the ATS 2013 International Conference.

"Several studies have found high rates of pain medication use among COPD patients, and pain has also been an important determinant of overall health status and quality of life in COPD," said study lead author Melissa Roberts, MS, senior research associate at the Lovelace Clinic Foundation in Albuquerque and a doctoral candidate at the University of New Mexico College of Pharmacy.

"In prior studies, we had observed increased narcotic and non-narcotic pain medication use among individuals with COPD and were interested in whether this was because the COPD population tends to be older and have more comorbidities, or whether there might be an association between COPD and pain above and beyond what age and comorbidities might explain," she said. "In this study, we chose to compare chronic pain in individuals with COPD and individuals with chronic conditions that similarly affect multiple body systems."

The retrospective study used data gathered from 7,952 COPD patients and 15,904 non-COPD patients over the age of 40 who were enrolled in a managed care system in the southwestern United States from 2006 through 2010. The presence of pain was determined by pain-associated diagnosis codes, the use of pain therapy and outpatient prescription claims for pain medication, and recurrent therapy and prescriptions were considered evidence of chronic pain.

The researchers found that compared to those with non-COPD chronic disease, a greater number of patients with COPD had some indication of chronic pain and use of pain-related medications, including both short-acting and long-acting opioids. However, chronic pain was not associated with lung function impairment among the study patients, suggesting the causes of pain are not directly associated with airflow obstruction. The only subset of patients with greater prevalence of chronic pain and use of pain medication were patients with either rheumatoid arthritis or osteoarthritis.

"We found the prevalence of chronic pain among adults with chronic disease to be almost twice as high as among individuals without chronic disease," Ms. Roberts noted. "Among those with chronic disease, individuals with COPD were similar to those with rheumatoid arthritis or osteoarthritis in their experience of pain, but with even greater use of opioids."

An investigation of the incremental costs associated with chronic pain is under way, she noted.

"The socioeconomic impact of chronic pain on patients with COPD is also an understudied issue, and many health care organizations conduct management programs for chronic diseases which significantly impact quality of life," Ms. Roberts said. "Among individuals with COPD, pain may be having a marked impact on their quality of life, potentially as much as their respiratory disease, and contributing significantly to their cost of care."
-end-
* Please note that numbers in this release may differ slightly from those in the abstract. Many of these investigations are ongoing; the release represents the most up-to-date data available at press time.

Abstract 40849

Chronic Pain Among Individuals With COPD As Compared To Other Chronic Diseases

Type: Scientific Abstract

Category: 09.03 - COPD: Comorbidities (CP)

Authors: M.H. Roberts1, D.W. Mapel1, A. Hartry2, A. Von Worley1, H. Thomson2; 1Lovelace Clinic Foundation - Albuquerque, NM/US, 2Endo Pharmaceuticals - Chadds Ford, PA/US

Abstract Body

Rationale. Several studies have found high rates of pain medication use among COPD patients. Pain has also been an important determinant of overall health status and quality of life in COPD. This project's objective was to describe chronic pain prevalence among COPD patients as compared to similar patients with other chronic diseases, and to compare factors associated with chronic pain in a matched analysis of COPD and non-COPD patients, supplemented by a sub-analysis of patients with spirometry information.

Methods: In this retrospective analysis (1/1/2006 through 12/31/2010) of managed care system enrollees (age >40) in the Southwestern U.S. pain was indicated by pain-associated diagnosis codes, pain therapy, or outpatient prescription claims for pain medication; and recurrent occurrences of such utilization was considered evidence of chronic pain. Patients were matched on age, sex, insurance coverage, type of healthcare encounter, and encounter date (+/- 6 months).

Results: Adjusted prevalence rates were similar across all study years; for brevity, rates for 2010 are stated. A higher percentage of those with COPD compared to those with non-COPD chronic disease had some indication of chronic pain (61.8% vs 53.9%, P<0.05) and evidence of chronic pain-related medication use (48.1% vs 35.7%, P<0.05). Matched Analysis. The cohort consisted of 7,952 COPD patients (mean age 69 years) and 15,904 non-COPD patients (mean age 68 years), 58% of whom were female. Evidence of chronic pain was similar to the unadjusted prevalence rates (COPD=59.8%, non-COPD=51.7%, P<0.0001). Non-COPD rheumatoid/osteoarthritis (RA/OA) patients had greater evidence of chronic pain (70.2%, P<0.0001) and chronic use of pain-related medications compared to COPD patients (44.8% vs 41.2%, P<0.0001), but for all other conditions, a higher percentage of COPD patients vs non-COPD had chronic use of pain-related medications (41.2% vs 31.5%, P<0.0001). Of those with evidence of chronic use of pain medications, more COPD patients had chronic use of short-acting opioids (24.2% vs 15.1%, P<0.0001) and long-acting opioids (4.4% vs 1.9%, P<0.0001). Among COPD patients, chronic pain patients tended to be female (64.0% vs 49.0%, p<0.0001)with a greater number of comorbidities (3.3 vs 2.7, p<0.0001), inflammatory pain (86.5% vs 45.7%, P<0.0001), and an inpatient or institutional stay (42.7% vs 25.4%, p<0.0001). Chronic pain was not associated with lung function impairment. Conclusion: The majority of COPD patients experience chronic pain at a rate that is outmatched only by persons with RA/OA. Short-acting and long-acting opiate use among COPD patients is accordingly higher.

American Thoracic Society

Related Rheumatoid Arthritis Articles:

Study examines opioid use in patients with rheumatoid arthritis
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly.
Studies examine rheumatoid arthritis patients' prognosis
What's the long-term outlook for today's patients with early rheumatoid arthritis?
Obesity may influence rheumatoid arthritis blood tests
New research reveals that in women, obesity may influence blood tests used to diagnose and monitor rheumatoid arthritis.
New tool for prognosis and choice of therapy for rheumatoid arthritis
In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints.
The promise of precision medicine for rheumatoid arthritis
In a new study, a Yale-led research team identified the mechanism of a gene that raises the risk of severe rheumatoid arthritis in susceptible individuals.
Immunotherapy reduces cardiovascular risk in rheumatoid arthritis
Weight loss from bariatric surgery appears to reverse the premature aging associated with obesity, according to research presented today at Frontiers in CardioVascular Biology 2016.
Osteoarthritis just as severe as rheumatoid arthritis
Rheumatologists more likely to underestimate clinical status of their OA patients than their RA patients
Serotonin deficiency implicated in rheumatoid arthritis
For the first time, serotonin (5-hydroxytryptamine, 5-HT) has been directly implicated in the pathophysiology of rheumatoid arthritis (RA).
Link between mood, pain in rheumatoid arthritis patients
Depressive symptoms and mood in the moment may predict momentary pain among rheumatoid arthritis patients, according to Penn State researchers.
Inflammation in the mouth and joints in rheumatoid arthritis
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled 'Inflammation in the Mouth and Joints in Rheumatoid Arthritis.' The IADR General Session is being held in conjunction with the 44th Annual Meeting of the American Association for Dental Research and the 39th Annual Meeting of the Canadian Association for Dental Research.

Related Rheumatoid Arthritis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...